BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22847453)

  • 1. The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy.
    Bañez LL; Albisinni S; Freedland SJ; Tubaro A; De Nunzio C
    World J Urol; 2014 Apr; 32(2):323-8. PubMed ID: 22847453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy.
    Oh JJ; Jeong SJ; Lee BK; Jeong CW; Byun SS; Hong SK; Lee SE
    BJU Int; 2013 Aug; 112(4):E265-71. PubMed ID: 23432960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
    Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
    Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
    Kim JH; Doo SW; Yang WJ; Lee KW; Lee CH; Song YS; Jeon YS; Kim ME; Kwon SS
    Int J Urol; 2014 Oct; 21(10):987-90. PubMed ID: 24825391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does obesity modify prostate cancer detection in a European cohort?
    Sanchis-Bonet A; Morales-Palacios N; Barrionuevo-Gonzalez M; Ortega-Polledo LE; Ortiz-Vico FJ; Sanchez-Chapado M
    Cent European J Urol; 2017; 70(1):30-36. PubMed ID: 28461985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.
    Vedder MM; de Bekker-Grob EW; Lilja HG; Vickers AJ; van Leenders GJ; Steyerberg EW; Roobol MJ
    Eur Urol; 2014 Dec; 66(6):1109-15. PubMed ID: 25168616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1).
    Chen R; Zhou LQ; Cai XB; Xie LP; Huang YR; He DL; Gao X; Xu CL; Ding Q; Wei Q; Yin CJ; Ren SC; Wang FB; Tian Y; Sun ZQ; Fu Q; Ma LL; Zheng JH; Ye ZQ; Ye DW; Xu DF; Hou JQ; Xu KX; Yuan JL; Gao X; Liu CX; Pan TJ; Sun YH;
    Asian J Androl; 2015; 17(6):1017-21. PubMed ID: 25926603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of digital rectal examination for prostate cancer detection is modified by obesity.
    Chu DI; De Nunzio C; Gerber L; Thomas JA; Calloway EE; Albisinni S; Senocak C; McKeever MG; Moreira DM; Tubaro A; Moul JW; Freedland SJ; Bañez LL
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):346-53. PubMed ID: 21727906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.
    Nordström T; Vickers A; Assel M; Lilja H; Grönberg H; Eklund M
    Eur Urol; 2015 Jul; 68(1):139-46. PubMed ID: 25151013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.
    Lee A; Lim J; Gao X; Liu L; Chia SJ
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e348-e355. PubMed ID: 27641069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies.
    Rais-Bahrami S; Siddiqui MM; Vourganti S; Turkbey B; Rastinehad AR; Stamatakis L; Truong H; Walton-Diaz A; Hoang AN; Nix JW; Merino MJ; Wood BJ; Simon RM; Choyke PL; Pinto PA
    BJU Int; 2015 Mar; 115(3):381-8. PubMed ID: 24447678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.
    Liang Y; Ankerst DP; Sanchez M; Leach RJ; Thompson IM
    Urology; 2010 Nov; 76(5):1268.e1-6. PubMed ID: 20739049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution.
    Kryvenko ON; Diaz M; Matoso A; Kates M; Cohen J; Swanson GP; Epstein JI
    Urology; 2016 Apr; 90():141-7. PubMed ID: 26773349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
    BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: The Impact of Obesity on the Predictive Accuracy of PSA in Men Undergoing Prostate Biopsy.
    Kaplan SA
    J Urol; 2015 Aug; 194(2):394-5. PubMed ID: 26195366
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between obesity and frequency of high-grade prostate cancer on biopsy in men: A single-center retrospective study.
    Baio R; Napodano G; Caruana C; Molisso G; Di Mauro U; Intilla O; Pane U; D'Angelo C; Francavilla AB; Guarnaccia C; Pentimalli F; Sanseverino R
    Mol Clin Oncol; 2022 Aug; 17(2):127. PubMed ID: 35832470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving prostate cancer detection in veterans through the development of a clinical decision rule for prostate biopsy.
    Hill OT; Mason TJ; Schwartz SW; Foulis PR
    BMC Urol; 2013 Jan; 13():6. PubMed ID: 23356551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.